Assure to Attend Investor Conferences in December 2022
30 November 2022 - 12:30AM
Assure Holdings Corp. (the “
Company” or
“
Assure”) (NASDAQ: IONM), a provider of
intraoperative neuromonitoring (“
IONM”) and remote
neurology services, announced that management will participate in
the following investor conferences in December 2022:
- The Benchmark Discovery One-on-One
Investor Conference on December 1, 2022. The conference offers
emerging growth and dynamic publicly traded companies access to
institutions and individuals in a unique one-on-one format. Assure
management will participate in one-on-one meetings with prospective
investors and other interested parties.
- Roth Capital Deer Valley Conference
on December 15-16, 2022. This invitation only event provides a
forum for public companies to tell their stories to investors.
One-on-one and group meetings will be held throughout the
conference.
Neither of these events include central presentations.
About Assure HoldingsAssure Holdings Corp. is a
best-in-class provider of outsourced intraoperative neuromonitoring
and remote neurology services. The Company delivers a turnkey suite
of clinical and operational services to support surgeons and
medical facilities during invasive procedures that place the
nervous system at risk including neurosurgery, spine,
cardiovascular, orthopedic and ear, nose and throat surgeries.
Assure employs highly trained technologists that provide a direct
point of contact in the operating room. Physicians employed through
Assure subsidiaries simultaneously monitor the functional integrity
of patients’ neural structures throughout the procedure
communicating in real-time with the surgeon and technologist.
Accredited by The Joint Commission, Assure’s mission is to provide
exceptional surgical care and a positive patient experience. For
more information, visit the company’s website
at www.assureneuromonitoring.com.
Forward-Looking Statements This news release
may contain “forward-looking statements” within the meaning of
applicable securities laws, including, but not limited to comments
with respect to: expectations with respect to the Company’s growth
and development and the quality and results of future services.
Forward-looking statements may generally be identified by the use
of the words "anticipates," "expects," "intends," "plans,"
"should," "could," "would," "may," "will," "believes," "estimates,"
"potential," "target," or "continue" and variations or similar
expressions. These statements are based upon the current
expectations and beliefs of management and are subject to certain
risks and uncertainties that could cause actual results to differ
materially from those described in the forward-looking statements.
These risks and uncertainties include, but are not limited to: the
uncertainty surrounding the spread of COVID-19 and the impact it
will have on the Company’s operations and business, its remote
neurology business, and economic activity in general; and risks and
uncertainties discussed in our most recent annual and quarterly
reports filed with the United States Securities and Exchange
Commission, including our annual report on Form 10-K filed on March
14, 2022, and available on the Company’s EDGAR profile
at www.sec.gov, which risks and uncertainties are incorporated
herein by reference. Except as required by law, Assure does not
intend, and undertakes no obligation, to update any forward-looking
statements to reflect, in particular, new information or future
events.
ContactScott Kozak, Investor and Media
RelationsAssure Holdings
Corp.1-720-617-2526Scott.Kozak@assureiom.com
Assure (NASDAQ:IONM)
Historical Stock Chart
From Mar 2024 to Mar 2024
Assure (NASDAQ:IONM)
Historical Stock Chart
From Mar 2023 to Mar 2024